Sign in
Not yet taking people in United StatesNo phase

EMST 150 Training in Mild-Moderate OSA

Key facts

Who runs it
University Hospitals Cleveland Medical Center
Where
Cleveland, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
20 people, planned
Starts
1 Dec 2026
Expected to end
1 Dec 2027
Type of study
Interventional
Treatments tested
  • Expiratory Muscle Strength Training Device (EMST 150)
  • Oropharyngeal Myofunctional Therapy (MT)
Record updated
17 November 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Clinical diagnosis of Mild-to-Moderate OSA (5<AHI<30 events/hour)
  • Patient willingness and physical capability to perform threshold-based respiratory exercises and daily oral myofunctional exercises
  • Documented failure, intolerance (defined as regular use < 4 hours/night), or patient refusal of standard therapies, including Continuous Positive Airway Pressure (CPAP) and surgical interventions

Who cannot take part

  • Recent esophageal surgery, recent abdominal surgery, or presence of an abdominal hernia
  • Active asthma, severe or poorly controlled asthma with low symptom perception, or severe chronic obstructive pulmonary disease (COPD)
  • Uncontrolled hypertension, defined as resting systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg at screening, or any change in antihypertensive medication within the past 30 days, or significant cardiovascular disease
  • History of spontaneous pneumothorax, or incomplete recovery/healing following traumatic pneumothorax or rib fracture
  • History of lung transplantation or lung resection
  • Tympanic membrane perforation (ruptured eardrum) or active inner/middle ear pathology
  • Unrelated or uncontrolled gastroesophageal reflux disease (GERD)
  • Any acute medical condition or clinical situation where generating intrathoracic, intro-abdominal, or intracranial pressure (similar to Valsalva maneuver) is clinically contraindicated
  • Severe OSA (AHI>30 events/hour)
  • Current tracheostomy or unhealed tracheostomy stoma
  • Presence of a cerebrospinal fluid (CSF) drain or active intracranial pressure monitoring
  • Active epistaxis (frequent/severe nosebleeds) or active hemoptysis within the past 30 days
  • Known or suspected pregnancy
  • Active use of CPAP, mandibular advancement device (MAD), or hypoglossal nerve stimulation (HGNS) during the study period

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Where in United States

  • University Hospitals Cleveland Medical Center*Cleveland, United StatesContact: Thomaz Fleury Curado, MDNot yet recruiting

About the trial

What the trial wants to find out

Obstructive Sleep Apnea is a condition in which the upper airway repeatedly becomes blocked during sleep, often due to weakness or collapse of the upper airway throat muscles. The purpose of this study is to evaluate whether combining a handheld breathing device (Expiratory Muscle Strength Training (EMST 150)) with structured, speech-language pathology-Guided mouth and throat exercises can help strengthen the muscles that keep the airway open, reduce snoring, and reduce sleep apnea severity while improving overall sleep quality. Participation in this study will last about 3 months. This includes a 5-week home breathing exercise program, two in-person clinic visits (at the beginning of the study and at Month 3), and two short phone check-ins.

The group in the trial

  • Participants with Obstructive Sleep Apnea (OSA)Treatment being tested

    Adult participants diagnosed with mild-to-moderate obstructive OSA.

    Treatment: Expiratory Muscle Strength Training Device (EMST 150) and Oropharyngeal Myofunctional Therapy (MT)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating the Efficacy and Feasibility of Combined Expiratory Muscle Strength Training (EMST 150) and Oropharyngeal Myofunctional Therapy in Patients With Mild-to-Moderate Obstructive Sleep Apnea.
Criteria questions
Built from NCT07942636, who can take part
Record updated
17 November 2026